Skip to main content
. 2018 May 22;9(6):599. doi: 10.1038/s41419-018-0623-9

Fig. 2. Pathway analyses of DEGs in specified comparisons.

Fig. 2

a Pathways significantly enriched in upregulated genes in DMBA-induced cancer vs. normal control. b Pathways significantly enriched in upregulated genes in DMBA-induced dysplasia versus normal control. c Pathways significantly enriched in downregulated genes in Sal-B-DMBA-treated group vs. DMBA-induced cancer. d Pathways significantly enriched in downregulated genes in Sal-B-DMBA-treated group vs. DMBA-induced dysplasia. The red frame indicated the significantly related pathways in this study